2-Acetyl-3,(5 or 6)-dimethylpyrazine
| Common Name: |
2-Acetyl-3,(5 or 6)-dimethylpyrazine |
| IUPAC Name: |
1-(3,5-dimethylpyrazin-1-ium-1-yl)ethanone |
| Molecular Formula: |
C14H22O4 |
| SMILES: |
CC1=C[N+](=CC(=N1)C)C(=O)C |
| Inchi: |
1S/C8H11N2O/c1-6-4-10(8(3)11)5-7(2)9-6/h4-5H,1-3H3/q+1 |
| Inchi Key: |
SRLOIFIDNDAVFM-UHFFFAOYSA-N |
| Cas No: |
72797-17-2 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
0 |
| Name |
Value |
| Molecular Weight (g/mol) |
254.32 |
| Mass (g/mol) |
151.087 |
| Molar Refractivity |
70.60 |
| Net Charge |
1 |
| HBD |
|
| HBA |
4 |
| Rt Bonds |
8 |
| Rings |
1 |
| TPSA |
36.92 |
| Hetero Atoms |
3 |
| Heavy Atoms |
18 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
70.00 @ 7.00 mm Hg |
| Vapor Pressure (mmHg@25.00 °C) |
3.000000mmHg@20.00 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.57 |
| LogP |
0.646 |
| iLOGP |
3.52 |
| XLOGP3 |
2.60 |
| WLOGP |
2.84 |
| MLOGP |
2.15 |
| ESOL Log S |
-2.77 |
| ESOL Solubility (mg/ml) |
0.428 |
| ESOL Solubility (mol/l) |
0.002 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-3.02 |
| Ali Solubility (mg/ml) |
0.24 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-4.18 |
| Silicos-IT Solubility (mg/ml) |
0.02 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Moderately soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.01 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.212 |
| CYP1A2 Inhibitor |
1 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
1 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.595 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
1 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
